Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: Association with disease progression, mode of invasion, and lymph node metastasis

Cancer

Volumn 88, Issue 2, 2000, Pages 245-254

  Nitta, Tetsuya ^a   Sugihara, Kazumasa ^a   Tsuyama, Shinichro ^b   Murata, Fusayoshi ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Immunohistochemistry; Invasion; Metastasis; MUC1 mucin; Oral premalignant lesions; Oral squamous cell carcinoma

Indexed keywords

MUCIN;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; EPITHELIUM DYSPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MOUTH CARCINOMA; PRECANCER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

CA-15-3 ANTIGEN; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS;

EID: 0034650187     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000115)88:2<245::AID-CNCR1>3.0.CO;2-T     Document Type: Article

References (38)

1. Spiro RH, Alfonoso AE, Farr HW, Strong EW. Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. Am J Surg 1974;128:562-7.
2. Kalnins IK, Leonard AG, Sako K, Razack MS, Shedd DP. Correlation between prognosis and degree of lymph node involvement in carcinoma of the oral cavity. Am J Surg 1977;134:450-4.
3. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184-94.
4. Gum JR. Mucin genes and the proteins they encode: structure, diversity, and regulation. Am J Respir Cell Mol Biol 1992;7:557-64.
5. Gendler SJ, Spicer AP, Lalani EN, Duhig T, Peat N, Burchell J, et al. Structure and biology of a carcinoma-associated mucin, MUC1. Am J Repir Dis 1991;144:S42-5.
6. Shankar V, Pichan P, Eddy R, Tonk V, Nowak N, Sait SNJ, et al. Chromosomal localization of a human mucin gene (MUC8) and cloning of the cDNA corresponding to the carboxyl terminus. Am J Respir Cell Mol Biol 1997;16:232-41.
7. Yonezawa S, Sato E, Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol Int 1997;47:813-30.
8. Ikeda Y, Kuwano H, Ikebe M, Baba K, Toh Y, Adachi Y, et al. Immunohistochemical detection of CEA, CA19-9, and DF3 In esophageal carcinoma limited to the submucosal layer. J Surg Oncol 1994;56:7-12.
9. McGuckin MA, Walsh MD, Hohn BG, Ward BG, Wright G. Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum Pathol 1995;26:432-9.
10. Kufe D, Inghirami G, Abe M, Hayes D, Justin Wheeler H, Schlom J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 1984;3:223-32.
11. Ohtani H, Nagura H, Ohuchi N. Immunoelectron microscopic localization of DF3 cancer-associated antigen in human breast cancer. Pathol Res Pract 1991;187:1014-9.
12. Beckfold U, Barbatis C, Beesley JE, Linsell JC, Chantler SM. Localization of CA and HMFG2 antigens in breast tissue by immunoperoxidase, immunofluorescence and immunoelectron microscopy. J Clin Pathol 1985;38:512-20.
13. Itoh T, Yonezawa S, Nomoto M, Ueno K, Kim YS, Sato E. Expression of mucin antigens and Lewis X-related antigens in carcinoma and dysplasia of the pharynx and larynx. Pathol Int 1996;46:646-55.
14. Nakamori S, Ota DM, Cleary KR, Shirotani K, Irimura T. MUC 1 mucin expression as a maker of progression and metastasis of human colorectal carcinoma. Gastroenterology 1994;106:353-61.
15. Tashiro Y, Yonezawa S, Kim YS, Sato E. Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors. Hum Pathol 1994;25:364-72.
16. Osako M, Yonezawa S, Siddiki B, Huang J, Ho JJL, Kim YS, et al. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. Cancer 1993;71:2191-9.
17. Yamashita K, Yonezawa S, Tanaka S, Shirahama H, Sakoda K, Imai K, et al. Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma. Int J Cancer 1993;55:82-91.
18. Sobin LH, Wittekind C, editors. TNM classification of malignant tumors. 5th ed. New York: Wiley-Liss, Inc., 1997.
19. Yamamoto E, Kohama G, Sunakawa H, Iwai M, Hiratuka H. Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer 1983; 51;2175-80.
20. Fogel M, Altevogt P, Schirrmacher V. Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation. J Exp Med 1983;157:371-6.
21. x antigen. Exp Cell Res 1991;196:20-5.
22. Nicolson GL. Cancer metastasis: organ colonization and the cell-surface properties of malignant cells. Biochem Biophys Acta 1982;695:113-76.
23. Sinohara M, Hiraki A, Ikebe T, Nakamura S, Kurahara S, Shirasuna K, et al. Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behavior. J Pathol 1998;184:369-81.
24. v integrins in oral squamous cell carcinoma. J Oral Pathol Med 1997;26:63-8.
25. Ue T, Yokozaki H, Kagai K, Higashikawa K, Yasui W, Sugiyama M, et al. Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis. J Oral Pathol Med 1998;27:197-201.
26. Hilkens J, Vos HL, Wesseling J, Boer M, van der Valk S, Calafat J. Is episialin/MUC1 involved in breast cancer progression ? Cancer Lett 1995;90:27-33.
27. Wesseling J, van der Valk SW, Vos HL, Sonnenberg A, Hilkens J. Episialin (MUC1) overexpresslon inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 1995;129:255-65.
28. Lightenberg MJL, Buijs F, Vos HL, Hilkens J. Suppression of cellular aggregation by high levels of episialin. Cancer Res 1992;52:2318-24.
29. Hudson MJH, Stamp GWH, Hollingsworth MA, Pignatelli M, Lalani E-N. MUC1 expressed in PanC1 cells decreases adhesion to type1 collagen but increases contraction in collagen lattices. Am J Pathol 1996;148:951-60.
30. van de Weil-van Kemenade E, Ligtenberg MJL, de Boer AJ, Buijs F, Vos HL, Melief CJM, et al. Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J Immunol 1993;151:767-76.
31. Litvinov SV, Hilkens J. The epithelial sialomucin, episialin, Is sialylated during recycling. J Biol Chem 1993;268:21364-71.
32. Siddiqui J, Abe M, Hayes D, Shani E, Yunis E, Kufe D. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci USA 1988;85:2320-3.
33. Hauri HP. Use of monoclonal antibodies to investigate the intracellular transport and biogenesis of intestinal brush-border proteins. Biochem Soc 1986;14:161-3.
34. Carraway CAC, Jung G, Hinkey RE, Carraway KL. Isolation of microvillar microfilaments and associated transmenbrane complex from ascites tumor cell microvilli. Exp Cell Res 1985;157:71-82.
35. Ren J, Hamada J, Takeichi N, Fujikawa S, Kobayashi H. Ultrastructural differences in junctional intercellular communication between highly and weakly metastatic clones derived from rat mammary carcinoma. Cancer Res 1990;50: 358-62.
36. Dennis L, Waller C, Timpl R, Schirrmacher V. Surface sialic acid reduces attachment of metastatic tumor cells to collagen type and fibronectin. Nature 1980;300:274-6.
37. Collard JG, Schijven JF, Bikker A, Riviere GL, Bolscher JGM, Roos E. Cell surface sialic acid and the invasion and metastatic potential of T-cell hybridomas. Cancer Res 1986;46:3521-7.
38. Papaniti A, Hart GW. Cell surface slalylation and tumor metastasis. J Biol Chem 1988;263:7591-603.